vs
Side-by-side financial comparison of M/I HOMES, INC. (MHO) and Zoetis (ZTS). Click either name above to swap in a different company.
Zoetis is the larger business by last-quarter revenue ($2.3B vs $1.1B, roughly 2.0× M/I HOMES, INC.). Zoetis runs the higher net margin — 26.6% vs 5.6%, a 21.0% gap on every dollar of revenue. On growth, Zoetis posted the faster year-over-year revenue change (2.9% vs -4.8%). Over the past eight quarters, M/I HOMES, INC.'s revenue compounded faster (4.7% CAGR vs -2.1%).
M/I Homes, Inc. is a leading U.S. residential construction company that designs, builds and sells single-family homes, townhomes and duplexes across multiple U.S. states. It caters to entry-level, move-up and luxury homebuyers, offering energy-efficient designs, flexible floor plans and personalized customization options.
Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total re...
MHO vs ZTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $2.3B |
| Net Profit | $64.0M | $601.0M |
| Gross Margin | 17.4% | 71.7% |
| Operating Margin | 6.5% | — |
| Net Margin | 5.6% | 26.6% |
| Revenue YoY | -4.8% | 2.9% |
| Net Profit YoY | -52.1% | -0.2% |
| EPS (diluted) | $2.42 | $1.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $2.3B | ||
| Q4 25 | $1.1B | $2.4B | ||
| Q3 25 | $1.1B | $2.4B | ||
| Q2 25 | $1.2B | $2.5B | ||
| Q1 25 | $976.1M | $2.2B | ||
| Q4 24 | $1.2B | $2.3B | ||
| Q3 24 | $1.1B | $2.4B | ||
| Q2 24 | $1.1B | $2.4B |
| Q1 26 | — | $601.0M | ||
| Q4 25 | $64.0M | $603.0M | ||
| Q3 25 | $106.5M | $721.0M | ||
| Q2 25 | $121.2M | $718.0M | ||
| Q1 25 | $111.2M | $631.0M | ||
| Q4 24 | $133.5M | $581.0M | ||
| Q3 24 | $145.4M | $682.0M | ||
| Q2 24 | $146.7M | $624.0M |
| Q1 26 | — | 71.7% | ||
| Q4 25 | 17.4% | 70.2% | ||
| Q3 25 | 24.5% | 71.5% | ||
| Q2 25 | 24.7% | 73.6% | ||
| Q1 25 | 25.9% | 72.0% | ||
| Q4 24 | 24.6% | 69.5% | ||
| Q3 24 | 27.1% | 70.6% | ||
| Q2 24 | 27.9% | 71.7% |
| Q1 26 | — | — | ||
| Q4 25 | 6.5% | 31.9% | ||
| Q3 25 | 12.0% | 37.0% | ||
| Q2 25 | 13.4% | 36.7% | ||
| Q1 25 | 14.4% | 36.5% | ||
| Q4 24 | 13.6% | 31.6% | ||
| Q3 24 | 15.9% | 36.6% | ||
| Q2 24 | 16.8% | 33.0% |
| Q1 26 | — | 26.6% | ||
| Q4 25 | 5.6% | 25.3% | ||
| Q3 25 | 9.4% | 30.0% | ||
| Q2 25 | 10.4% | 29.2% | ||
| Q1 25 | 11.4% | 28.4% | ||
| Q4 24 | 11.1% | 25.1% | ||
| Q3 24 | 12.7% | 28.6% | ||
| Q2 24 | 13.2% | 26.4% |
| Q1 26 | — | $1.42 | ||
| Q4 25 | $2.42 | $1.37 | ||
| Q3 25 | $3.92 | $1.63 | ||
| Q2 25 | $4.42 | $1.61 | ||
| Q1 25 | $3.98 | $1.41 | ||
| Q4 24 | $4.71 | $1.29 | ||
| Q3 24 | $5.10 | $1.50 | ||
| Q2 24 | $5.12 | $1.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.2B | — |
| Total Assets | $4.8B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.6B |
| Q1 26 | — | — | ||
| Q4 25 | $3.2B | $3.3B | ||
| Q3 25 | $3.1B | $5.4B | ||
| Q2 25 | $3.1B | $5.0B | ||
| Q1 25 | $3.0B | $4.7B | ||
| Q4 24 | $2.9B | $4.8B | ||
| Q3 24 | $2.8B | $5.2B | ||
| Q2 24 | $2.7B | $5.0B |
| Q1 26 | — | — | ||
| Q4 25 | $4.8B | $15.5B | ||
| Q3 25 | $4.8B | $15.2B | ||
| Q2 25 | $4.7B | $14.5B | ||
| Q1 25 | $4.6B | $14.1B | ||
| Q4 24 | $4.5B | $14.2B | ||
| Q3 24 | $4.5B | $14.4B | ||
| Q2 24 | $4.3B | $14.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.7M | — |
| Free Cash FlowOCF − Capex | $-13.0M | — |
| FCF MarginFCF / Revenue | -1.1% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | -0.14× | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-8.7M | $893.0M | ||
| Q3 25 | $43.4M | $938.0M | ||
| Q2 25 | $37.8M | $486.0M | ||
| Q1 25 | $64.9M | $587.0M | ||
| Q4 24 | $104.4M | $905.0M | ||
| Q3 24 | $-67.9M | $951.0M | ||
| Q2 24 | $27.5M | $502.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-13.0M | $732.0M | ||
| Q3 25 | $42.0M | $805.0M | ||
| Q2 25 | $35.1M | $308.0M | ||
| Q1 25 | $63.5M | $438.0M | ||
| Q4 24 | $102.3M | $689.0M | ||
| Q3 24 | $-68.5M | $784.0M | ||
| Q2 24 | $22.0M | $370.0M |
| Q1 26 | — | — | ||
| Q4 25 | -1.1% | 30.7% | ||
| Q3 25 | 3.7% | 33.5% | ||
| Q2 25 | 3.0% | 12.5% | ||
| Q1 25 | 6.5% | 19.7% | ||
| Q4 24 | 8.5% | 29.7% | ||
| Q3 24 | -6.0% | 32.8% | ||
| Q2 24 | 2.0% | 15.7% |
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 6.7% | ||
| Q3 25 | 0.1% | 5.5% | ||
| Q2 25 | 0.2% | 7.2% | ||
| Q1 25 | 0.1% | 6.7% | ||
| Q4 24 | 0.2% | 9.3% | ||
| Q3 24 | 0.1% | 7.0% | ||
| Q2 24 | 0.5% | 5.6% |
| Q1 26 | — | — | ||
| Q4 25 | -0.14× | 1.48× | ||
| Q3 25 | 0.41× | 1.30× | ||
| Q2 25 | 0.31× | 0.68× | ||
| Q1 25 | 0.58× | 0.93× | ||
| Q4 24 | 0.78× | 1.56× | ||
| Q3 24 | -0.47× | 1.39× | ||
| Q2 24 | 0.19× | 0.80× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MHO
| Southern Homebuilding | $615.6M | 54% |
| Northern Homebuilding | $503.9M | 44% |
| Financial Service | $27.8M | 2% |
| Land | $4.7M | 0% |
ZTS
| Companion Animal | $1.5B | 67% |
| Livestock | $720.0M | 32% |
| Contract Manufacturing & Human Health | $23.0M | 1% |
